Achieve Life Sciences Statistics
Total Valuation
ACHV has a market cap or net worth of $192.20 million. The enterprise value is $170.75 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHV has 53.24 million shares outstanding. The number of shares has increased by 35.93% in one year.
| Current Share Class | 53.24M |
| Shares Outstanding | 53.24M |
| Shares Change (YoY) | +35.93% |
| Shares Change (QoQ) | +4.43% |
| Owned by Insiders (%) | 4.91% |
| Owned by Institutions (%) | 46.89% |
| Float | 47.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.93 |
| P/TBV Ratio | 9.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.70.
| Current Ratio | 4.39 |
| Quick Ratio | 4.01 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -67.01 |
Financial Efficiency
Return on equity (ROE) is -257.67% and return on invested capital (ROIC) is -101.89%.
| Return on Equity (ROE) | -257.67% |
| Return on Assets (ROA) | -85.30% |
| Return on Invested Capital (ROIC) | -101.89% |
| Return on Capital Employed (ROCE) | -167.79% |
| Weighted Average Cost of Capital (WACC) | 14.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.95M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.60% in the last 52 weeks. The beta is 1.96, so ACHV's price volatility has been higher than the market average.
| Beta (5Y) | 1.96 |
| 52-Week Price Change | +65.60% |
| 50-Day Moving Average | 3.94 |
| 200-Day Moving Average | 3.80 |
| Relative Strength Index (RSI) | 51.19 |
| Average Volume (20 Days) | 842,993 |
Short Selling Information
The latest short interest is 7.12 million, so 13.37% of the outstanding shares have been sold short.
| Short Interest | 7.12M |
| Short Previous Month | 7.01M |
| Short % of Shares Out | 13.37% |
| Short % of Float | 15.10% |
| Short Ratio (days to cover) | 20.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -54.88M |
| Pretax Income | -54.65M |
| Net Income | -54.65M |
| EBITDA | -54.65M |
| EBIT | -54.88M |
| Earnings Per Share (EPS) | -$1.25 |
Full Income StatementBalance Sheet
The company has $36.40 million in cash and $14.96 million in debt, with a net cash position of $21.45 million or $0.40 per share.
| Cash & Cash Equivalents | 36.40M |
| Total Debt | 14.96M |
| Net Cash | 21.45M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 21.52M |
| Book Value Per Share | 0.40 |
| Working Capital | 30.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$49.47 million and capital expenditures -$3,000, giving a free cash flow of -$49.47 million.
| Operating Cash Flow | -49.47M |
| Capital Expenditures | -3,000 |
| Depreciation & Amortization | 228,000 |
| Net Borrowing | 5.00M |
| Free Cash Flow | -49.47M |
| FCF Per Share | -$0.93 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.93% |
| Shareholder Yield | -35.93% |
| Earnings Yield | -28.43% |
| FCF Yield | -25.74% |
Analyst Forecast
The average price target for ACHV is $15.50, which is 329.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.50 |
| Price Target Difference | 329.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 31, 2020. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jul 31, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
